Ann: Results of Entitlement Offer, page-26

First 26 Last

Share
Profile

Follow
BC1954

106 Posts.

20

23/05/25

14:43

Post #: 79165316
Share

Originally posted by MongooseMan: ↑

That's not surprising. When you pay somebody a salary that puts them probably in the top 0.1% of Australian salaries but there's a perception of bottom quintile performance, I can fully understand the irritation, must stick in your craw to know you and your fellow SHs are covering these generous salaries (the company CSO isn't shabbily paid either). It would be an interesting exercise to look at Australian biotech, most of which frankly is an ocean of mediocrity IMO, and correlate compensation largesse with actual performance.
If they have not started the p3 trial despite an alleged ethics approval in November, and in fact the corporate deck from this month confirms they expect recruitment to start "this quarter" so they obviously haven't started, this is IMO appallingly dilatory progress, somebody is not doing their job and in any performance-based company would have been shown the door. The fact this same corporate deck has nothing on the actual p3 study design, even a basic outline, is also poor. I'm staying well away from this one....

Expand

FYI the CSO is the daughter of the founder, Graham Melrose and the Auntie of the CEO.
Say no more, hey.
Also this is her only experience in a bio tech company!

RCE Price at posting: 29.0¢ Sentiment: None Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

AVM

'Sure to be busy': Advance's Yuquivo drilling gets off to top start with first-hole hits

Listen: HotCopper Wire Podcast 013 - They changed the IPO rules (and that's a good thing)

STO

Santos jumps +15% as ADNOC takeover deal digested

4DS

4DS Memory tanks as microchip tech tests fail to produce result

THL

Today's top gainer stock isn't an energy player. Here's what's going on

First 26 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 30.0¢		Change -0.015(4.76%)		Mkt cap ! $89.39M

Open	High	Low	Value	Volume
31.0¢	31.0¢	30.0¢	$3.036K	9.817K

Buyers (Bids)

No.	Vol.	Price($)
6	33624	30.0¢

Sellers (Offers)

Price($)	Vol.	No.
31.0¢	96259	4

View Market Depth

No.	Vol.	Price($)
5	33334	0.300
2	100523	0.295
7	35706	0.290
2	35324	0.285
10	169420	0.280

Price($)	Vol.	No.
0.310	96259	4
0.315	6827	2
0.320	1208	2
0.325	523	1
0.330	25000	1

Last trade - 12.25pm 16/06/2025 (20 minute delay)

RCE (ASX) Chart

Ann: Results of Entitlement Offer, page-26

'Sure to be busy': Advance's Yuquivo drilling gets off to top start with first-hole hits

Listen: HotCopper Wire Podcast 013 - They changed the IPO rules (and that's a good thing)

Santos jumps +15% as ADNOC takeover deal digested

4DS Memory tanks as microchip tech tests fail to produce result

Today's top gainer stock isn't an energy player. Here's what's going on

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Results of Entitlement Offer, page-26

Top Stories

'Sure to be busy': Advance's Yuquivo drilling gets off to top start with first-hole hits

Listen: HotCopper Wire Podcast 013 - They changed the IPO rules (and that's a good thing)

Santos jumps +15% as ADNOC takeover deal digested

4DS Memory tanks as microchip tech tests fail to produce result

Today's top gainer stock isn't an energy player. Here's what's going on

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News